PlainRecalls
FDA Drug Moderate Class II Terminated

Simvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 count-bottle (NDC 43063-0726-30) b) 90 count-bottle (NDC 43063-0726-90)

Reported: May 10, 2023 Initiated: April 6, 2023 #D-0561-2023

Product Description

Simvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 count-bottle (NDC 43063-0726-30) b) 90 count-bottle (NDC 43063-0726-90)

Reason for Recall

CGMP deviations.

Details

Units Affected
393 bottles
Distribution
Nationwide in the US.
Location
Oklahoma City, OK

Frequently Asked Questions

What product was recalled?
Simvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 count-bottle (NDC 43063-0726-30) b) 90 count-bottle (NDC 43063-0726-90). Recalled by PD-Rx Pharmaceuticals, Inc.. Units affected: 393 bottles.
Why was this product recalled?
CGMP deviations.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 10, 2023. Severity: Moderate. Recall number: D-0561-2023.